Savvy Updates, 1/17/22: Dexcom G7 Update with Kevin Sayer, “Medical” Wearables, NAFLD & T1D, Pancreatic Exocrine Insufficiency, Stair Walking & Insulin Sensitivity
Fitbit and Apple know their smartwatches aren’t medical devices. But do you? was written by Lisa Eadicicco for cnet.com, 14 January 2022. The line is blurring as wearables become more advanced. And it’s only getting more complicated. The Fitbit Sense...
Savvy Update 1/10/22: Dexcom G7?, Abbott Announces Lingo Sensor, Covid & T1D with Dr. Stephen Ponder, All About Vitamin D
What’s Going on with the Dexcom G7? was reported by Ross Wollen for DiabetesDaily.com, 3 January 2022. What’s going on with the Dexcom G7? Patients (and investors) want to know! Dexcom has been hyping the next generation of its groundbreaking continuous glucose...
Savvy Food & Exercise 1/5/22: Food Trends in 2022 and Health Benefits of Exercise
HAPPY NEW YEAR! Resolutions? Food? Exercise? Let’s take a look … How Will Americans Eat in 2022? was written by Kim Severson for the Food Section of TheNewYorkTimes.com, 28 December 2021. Last year at this time,...
Savvy Updates, 1/3/22: Beta Bionics Pivotal Trial, Log4j Cybersecurity, Exercise at High Altitudes, Cannabis and DKA, Amazon Pharmacy Shake-up, Endo Fellowships
Beta Bionics Announces Data Lock of the Insulin-Only Bionic Pancreas Pivotal Trial and Enrollment into the Screening Protocol of the Bihormonal Bionic Pancreas Pivotal Trial was released by Beta Bionics on GlobeNewswire.com, 22 December 2021. Beta Bionics,...
More Diabetes Blogs